• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补偿效应对阿片类药物依赖的年轻成年人临床试验数据收集的影响。

Compensation effects on clinical trial data collection in opioid-dependent young adults.

机构信息

Department of Psychiatry, University of New Mexico, Albuquerque, 87131, USA.

出版信息

Am J Drug Alcohol Abuse. 2012 Jan;38(1):81-6. doi: 10.3109/00952990.2011.600393. Epub 2011 Sep 22.

DOI:10.3109/00952990.2011.600393
PMID:21936751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3745824/
Abstract

BACKGROUND

Attrition in studies of substance use disorder treatment is problematic, potentially introducing bias into data analysis.

OBJECTIVES

This study aimed to determine the effect of participant compensation amounts on rates of missing data and observed rates of drug use.

METHODS

We performed a secondary analysis of a clinical trial of buprenorphine/naloxone among 152 treatment-seeking opioid-dependent subjects aged 15-21 during participation in a randomized trial. Subjects were randomized to a 2-week detoxification with buprenorphine/naloxone (DETOX; N = 78) or 12 weeks buprenorphine/naloxone (BUP; N = 74). Participants were compensated $5 for weekly urine drug screens and self-reported drug use information and $75 for more extensive assessments at weeks 4, 8, and 12.

RESULTS

Though BUP assignment decreased the likelihood of missing data, there were significantly less missing data at 4, 8, and 12 weeks than other weeks, and the effect of compensation on the probability of urine screens being positive was more pronounced in DETOX subjects.

CONCLUSION

These findings suggest that variations in the amount of compensation for completing assessments can differentially affect outcome measurements, depending on treatment group assignment.

SCIENTIFIC SIGNIFICANCE

Adequate financial compensation may minimize bias when treatment condition is associated with differential dropout and may be a cost-effective way to reduce attrition. Moreover, active users may be more likely than non-active users to drop out if compensation is inadequate, especially in control groups or in groups who are not receiving active treatment.

摘要

背景

在物质使用障碍治疗研究中,人员流失是一个问题,这可能会给数据分析带来偏差。

目的

本研究旨在确定参与者补偿金额对缺失数据率和观察到的药物使用率的影响。

方法

我们对一项为期 15-21 岁的阿片类药物依赖者接受丁丙诺啡/纳洛酮治疗的临床试验进行了二次分析,这些参与者参加了一项随机试验。参与者被随机分配到丁丙诺啡/纳洛酮 2 周脱毒(DETOX;N=78)或丁丙诺啡/纳洛酮 12 周(BUP;N=74)。参与者每周进行尿液药物筛查和自我报告的药物使用信息,可获得 5 美元的报酬,在第 4、8 和 12 周进行更广泛的评估时,可获得 75 美元的报酬。

结果

尽管 BUP 组减少了缺失数据的可能性,但在第 4、8 和 12 周时,缺失数据明显较少,而补偿对 DETOX 组尿液筛查阳性概率的影响更为显著。

结论

这些发现表明,完成评估的补偿金额的变化可能会根据治疗组的分配,对结果测量产生不同的影响。

科学意义

充足的经济补偿可能会最大限度地减少因治疗条件不同而导致的偏差,并且可能是一种降低人员流失率的具有成本效益的方法。此外,如果补偿不足,积极使用者比非积极使用者更有可能退出,尤其是在对照组或未接受积极治疗的组中。

相似文献

1
Compensation effects on clinical trial data collection in opioid-dependent young adults.补偿效应对阿片类药物依赖的年轻成年人临床试验数据收集的影响。
Am J Drug Alcohol Abuse. 2012 Jan;38(1):81-6. doi: 10.3109/00952990.2011.600393. Epub 2011 Sep 22.
2
Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants.青少年阿片类药物依赖临床试验参与者的自我报告和尿液药物筛查数据的一致性。
Addict Behav. 2013 Oct;38(10):2568-74. doi: 10.1016/j.addbeh.2013.05.015. Epub 2013 Jun 13.
3
Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial.延长丁丙诺啡-纳洛酮治疗对阿片类药物依赖青少年的成本效益:一项随机试验的数据。
Addiction. 2010 Sep;105(9):1616-24. doi: 10.1111/j.1360-0443.2010.03001.x. Epub 2010 Jul 12.
4
Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.阿片类药物依赖青少年丁丙诺啡/纳洛酮治疗脱落的预测因素。
Addict Behav. 2012 Sep;37(9):1046-53. doi: 10.1016/j.addbeh.2012.04.011. Epub 2012 May 8.
5
Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction.慢性疼痛严重程度的波动性和变化可预测处方阿片类药物成瘾的治疗结果。
Addiction. 2017 Jul;112(7):1202-1209. doi: 10.1111/add.13782. Epub 2017 Feb 28.
6
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial.长效与短效丁丙诺啡-纳洛酮治疗阿片类药物成瘾青少年:一项随机试验
JAMA. 2008 Nov 5;300(17):2003-11. doi: 10.1001/jama.2008.574.
7
Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth.戒断预测因素:国家药物滥用研究所多地点丁丙诺啡/纳洛酮治疗阿片类药物依赖青少年的试验。
J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1120-8. doi: 10.1016/j.jaac.2011.07.010.
8
Therapy Dose Mediates the Relationship Between Buprenorphine/Naloxone and Opioid Treatment Outcomes in Youth Receiving Medication for Opioid Use Disorder Treatment.治疗剂量介导了丁丙诺啡/纳洛酮与接受阿片类物质使用障碍治疗药物的青少年阿片类药物治疗结果之间的关系。
J Addict Med. 2022;16(2):e97-e104. doi: 10.1097/ADM.0000000000000861.
9
A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic.一项关于阿片类药物依赖青少年和年轻人在门诊丁丙诺啡/纳洛酮诊所治疗留存率的回顾性研究。
J Addict Med. 2014 May-Jun;8(3):176-82. doi: 10.1097/ADM.0000000000000035.
10
Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.丁丙诺啡-纳洛酮与纳曲酮长效制剂预防阿片类药物复吸的成本效益比较。
Ann Intern Med. 2019 Jan 15;170(2):90-98. doi: 10.7326/M18-0227. Epub 2018 Dec 18.

引用本文的文献

1
Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders.物质使用障碍随机试验中尿液毒理学及其他生物样本缺失的预测因素。
Drug Alcohol Depend. 2024 Aug 1;261:111368. doi: 10.1016/j.drugalcdep.2024.111368. Epub 2024 Jun 12.
2
Extended-Release Injectable Naltrexone (XR-NTX) With Intensive Psychosocial Therapy for Amphetamine-Dependent Persons Seeking Treatment: A Placebo-Controlled Trial.长效注射用纳曲酮(XR-NTX)联合强化心理社会治疗用于寻求治疗的苯丙胺依赖者:一项安慰剂对照试验。
J Addict Med. 2017 May/Jun;11(3):197-204. doi: 10.1097/ADM.0000000000000297.
3
Buprenorphine for managing opioid withdrawal.丁丙诺啡用于管理阿片类药物戒断。
Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD002025. doi: 10.1002/14651858.CD002025.pub5.
4
Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine.当前使用阿片类药物并不会减弱对灭活流感疫苗的体液免疫反应。
Vaccine. 2016 Mar 8;34(11):1363-9. doi: 10.1016/j.vaccine.2016.01.051. Epub 2016 Feb 6.
5
Updated systematic review identifies substantial number of retention strategies: using more strategies retains more study participants.更新的系统评价确定了大量的保留策略:采用更多策略可留住更多研究参与者。
J Clin Epidemiol. 2015 Dec;68(12):1481-7. doi: 10.1016/j.jclinepi.2015.04.013. Epub 2015 Jun 10.
6
Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.在大多数接受门诊诱导治疗的阿片类药物依赖患者中进行了长效纳曲酮注射:一项极低剂量纳曲酮和丁丙诺啡开放标签试验。
Drug Alcohol Depend. 2014 May 1;138:83-8. doi: 10.1016/j.drugalcdep.2014.02.002. Epub 2014 Feb 15.
7
Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants.青少年阿片类药物依赖临床试验参与者的自我报告和尿液药物筛查数据的一致性。
Addict Behav. 2013 Oct;38(10):2568-74. doi: 10.1016/j.addbeh.2013.05.015. Epub 2013 Jun 13.

本文引用的文献

1
Investigating the missing data mechanism in quality of life outcomes: a comparison of approaches.探究生活质量结果中的缺失数据机制:方法比较
Health Qual Life Outcomes. 2009 Jun 22;7:57. doi: 10.1186/1477-7525-7-57.
2
Effectiveness of very low-cost contingency management in a community adolescent treatment program.极低成本应急管理在社区青少年治疗项目中的有效性。
Drug Alcohol Depend. 2009 Jun 1;102(1-3):162-5. doi: 10.1016/j.drugalcdep.2009.01.010. Epub 2009 Feb 27.
3
Stereotyping and the treatment of missing data for drug and alcohol clinical trials.药物和酒精临床试验中的刻板印象与缺失数据处理
Subst Abuse Treat Prev Policy. 2009 Feb 18;4:2. doi: 10.1186/1747-597X-4-2.
4
The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials.失访对药物滥用临床试验中几种统计方法治疗效果假设检验的影响。
J Subst Abuse Treat. 2009 Jul;37(1):54-63. doi: 10.1016/j.jsat.2008.09.011. Epub 2008 Nov 13.
5
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial.长效与短效丁丙诺啡-纳洛酮治疗阿片类药物成瘾青少年:一项随机试验
JAMA. 2008 Nov 5;300(17):2003-11. doi: 10.1001/jama.2008.574.
6
Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion.更高额度的现金支付可提高研究随访率,且不会增加药物使用或感知到的胁迫。
Drug Alcohol Depend. 2008 Jul 1;96(1-2):128-35. doi: 10.1016/j.drugalcdep.2008.02.007. Epub 2008 Apr 18.
7
A meta-analytic review of psychosocial interventions for substance use disorders.对物质使用障碍的心理社会干预措施的荟萃分析综述。
Am J Psychiatry. 2008 Feb;165(2):179-87. doi: 10.1176/appi.ajp.2007.06111851. Epub 2008 Jan 15.
8
Does size matter? Salience of follow-up payments in drug abuse research.规模重要吗?药物滥用研究中后续付款的显著性。
IRB. 2007 Jul-Aug;29(4):15-9.
9
The need for evidence-based research ethics: a review of the substance abuse literature.循证研究伦理的必要性:对药物滥用文献的综述
Drug Alcohol Depend. 2007 Jan 12;86(2-3):95-105. doi: 10.1016/j.drugalcdep.2006.06.011. Epub 2006 Aug 22.
10
Do research payments precipitate drug use or coerce participation?研究报酬会促使吸毒还是强迫参与?
Drug Alcohol Depend. 2005 Jun 1;78(3):275-81. doi: 10.1016/j.drugalcdep.2004.11.011. Epub 2005 Jan 23.